Adverum Biotechnologies to Host a Conference Call and Webcast to Report Third Quarter 2019 Financial Results and Provide Corp...
October 31 2019 - 4:01PM
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene
therapy company targeting unmet medical needs in ocular and rare
diseases, today announced today announced that it will host a
conference call and audio webcast on Thursday, November 7, 2019 at
1:30 PM Pacific Time (4:30 PM Eastern Time) to report its third
quarter 2019 financial results and provide corporate updates.
Individuals can participate in the conference call by dialing
1-866-420-8347 (domestic) or 1-409-217-8241 (international) and
refer to the “Adverum Biotechnologies Third Quarter 2019 Earnings
Call.” The webcast will be accessible under Events and
Presentations in the Investors section of the Company's website.
The archived audio webcast will be available on the Adverum website
following the call and will be available for 30 days.
About Adverum Biotechnologies, Inc.Adverum is a
clinical-stage gene therapy company targeting unmet medical needs
in ocular and rare diseases. Adverum develops gene therapy product
candidates designed to provide durable efficacy by inducing
sustained expression of a therapeutic protein. Adverum’s core
capabilities include clinical development, novel vector discovery
and in-house manufacturing expertise, specifically in scalable
process development, assay development, and current Good
Manufacturing Practices quality control. For more information,
please visit www.adverum.com.
Investor and Media Inquiries:
Investors:Myesha LacyAdverum BiotechnologiesVice President,
Investor Relations and Corporate
Communicationsmlacy@adverum.com1-650-304-3892
Media:Cherilyn Cecchini, M.D.Account
Supervisorccecchini@lifescipublicrelations.com 1-646-876-5196
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Apr 2023 to Apr 2024